AbbVie partners with IGI Therapeutics for ISB 2001, a potential cancer and autoimmune therapy. Read more here.

IGI Therapeutics SA, a wholly-owned subsidiary of Ichnos Glenmark Innovation (IGI)—an alliance between Glenmark Pharma and Ichnos Sciences Inc.—has signed an exclusive licensing agreement with AbbVie ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie.

And AbbVie’s rheumatoid arthritis pill upadacitiniub, also known as ABT-494, has succeeded in several late-stage studies and AbbVie plans filings in the second half of this year.

The global Monoclonal Antibodies Market was valued at USD 186 Billion in 2021 and is projected to exhibit a CAGR of 12% from ...